#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bladder cancer Lip and/or oral cavity cancer Becker's muscular dystrophy Canavan disease B-cell type acute leukaemia Prophylaxis against transplant rejection Neuropathy peripheral Osteochondrodysplasia Diffuse large B-cell lymphoma recurrent Giant cell tumour of tendon sheath Adult T-cell lymphoma/leukaemia refractory Cardiomyopathy Acquired ATTR amyloidosis Pseudoxanthoma elasticum Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency More trials…

    Learn about Rare Diseases

    Osteosarcoma – Basic Information Myelodysplastic syndrome – Trials in Disease X-linked lymphoproliferative syndrome – Diagnostics IgA nephropathy – Life with Disease Hairy cell leukaemia recurrent – Diagnostics Bronchopulmonary dysplasia – Trials in Disease Retinitis pigmentosa – Diagnostics Anaplastic thyroid cancer – Life with Disease Activated PI3 kinase delta syndrome – Life with Disease Chronic granulomatous disease – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bendamustine Hydrochloride Berubicin Hydrochloride Human Plasma Protein Tafasitamab Oleclumab Forimtamig Digoxin Immune Fab (Ovine) Nefopam Lolium Perenne F1245/05 Glucose, Anhydrous Ngi226 Basiliximab RNMB2 Levocetirizine Dihydrochloride Bhv-7000 Norfloxacin Chlorpromazine Hydrochloride Epacadostat Meloxicam More therapies…

    Learn about Your Condition

    Rett syndrome Fibrosarcoma Tourette's disorder Aicardi-Goutieres syndrome Coronary artery bypass Mantle cell lymphoma recurrent Ventricular tachycardia Biliary cancer metastatic Acquired ATTR amyloidosis Cirrhosis alcoholic Acute lymphocytic leukaemia Bone metabolism disorder Dermatitis Prolymphocytic leukaemia Myocardial ischaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. EVAGGELISMOS”General Hospital of Athens

EVAGGELISMOS”General Hospital of Athens

Ipsiladou 45-47, Athens, 106 76, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Long-Term Follow-Up Study for Patients Treated with Idecabtagene Vicleucel or Lisocabtagene Maraleucel for Cancer

    Recruiting

    4 1 1
    Investigated Drugs:
    • ARLOCABTAGENE AUTOLEUCEL
    • CC-97540
    • Idecabtagene Vicleucel
    Austria Belgium Czechia Denmark Finland France +11

  • Study Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • ARLOCABTAGENE AUTOLEUCEL
    • Dexamethasone Sodium Phosphate
    • Carfilzomib
    Austria Belgium Czechia Denmark Finland France +11

  • Clarithromycin to prevent secondary infections in adult patients with community-acquired pneumonia-related sepsis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Clarithromycin
    • Water For Injection
    • Glucose Monohydrate
    Greece

  • Study on the Safety and Effects of AB8939 and Azacitidine for Patients with Relapsed or Refractory Acute Myeloid Leukemia

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • 1-{4-[2-(5-Ethoxymethyl-2-Methyl-Phenylamino)-Oxazol-5-Yl]-Phenyl}-Imidazolidin-2-One
    • Azacitidine
    • Venetoclax
    France Germany Greece Spain

  • Study on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Lutikizumab
    • Adalimumab
    Austria Belgium Bulgaria Croatia Estonia France +12

  • Study on the Effects of Rapcabtagene Autoleucel and Drug Combination for Patients with Severe Refractory Inflammatory Muscle Diseases

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Rapcabtagene Autoleucel
    • Tacrolimus
    • Cyclophosphamide
    Austria Belgium Czechia Finland France Germany +7

  • A study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn’s disease or ulcerative colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Austria Belgium Bulgaria Croatia Czechia France +8

  • Study on the Effectiveness and Safety of SAR441566 for Adults with Moderate-to-Severe Ulcerative Colitis

    Not recruiting

    2 1
    Austria Belgium Bulgaria Croatia Czechia France +6

  • Study on the Effectiveness of Clindamycin and Tretinoin Gel for Treating Acne in Patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Clindamycin
    • Tretinoin
    Greece

  • Study of Isatuximab with drug combination for newly diagnosed multiple myeloma patients with severe kidney problems

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Bortezomib
    • Cyclophosphamide Monohydrate
    • Dexamethasone
    Greece
Previous Page
1 2 3 4 5 6
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!